thank stand welcome west pharmaceutical service earn conference call operator instruction would like turn conference speaker today vice president investor relation begin vice president investor relation thank good morning welcome west fourth quarter full year conference call issue financial result morning release post investor section company website locate westpharma morning green review financial result provide update business present update financial outlook full year slide presentation accompany today call copy presentation available investor section website slide safe harbor statement statement make management call accompany presentation contain forward look statement within mean federal security statement base belief assumption current expectation estimate forecast company future result influence many factor beyond control company actual result could differ materially past result express imply forward look statement make please refer today press release disclosure make company regard risk subject include report today call management make reference financial measure include organic sale growth adjust operate profit adjust operate profit margin adjust dilute reconciliation limitation financial measure comparable financial result prepare conform provide morning earn release turn call west president green green chief executive officer thank good morning thank join today excite result outlook start slide west deliver remarkable year success reflect year three thing stand first purpose serve improve patient life understand criticality role containment delivery life save life change medicine include battle member rally together great strength resolve meet accelerate customer demand want acknowledge incredible effort thank second prove market lead strategy continue meet shift market customer need unique value proposition across business segment evident continue strength financial performance lastly trust customer trust west global leader customer come west know deliver superior value high quality product solution remain focus deliver value stakeholder sustainable basis part support healthcare industry highlight slide exceptional year sale margin expansion drive strong demand base business accelerate demand component associate vaccine therapeutic year organic sale growth fourth quarter adjust relate sale base business grow teen organically proprietary product segment lead organic sale growth fuel high value product result impressive gross operate margin expansion quarter look ahead position right growth strategy around execute innovate grow commit order book time high continue realize benefit globalization operate model continue capital investment support increase demand drive attractive market turn slide addition financial momentum west several notable accomplishment ship billion component touch billion patient life continue safety member priority importance ensure continuity supply customer scientific technical leader industry continue broaden insight expertise west knowledge center webinars publish article technical presentation launch five product extension continue bring additional value customer donate million importantly hour volunteer hour donate member help local community greatest need move slide strive steward sustainable future factor environmental consideration every aspect business expand transparency report align task force climate relate financial disclosure recommendation include reduce energy dependency lessen emission production renewable greener energy develop carbon friendly product actively engage stakeholder seek opportunity impact climate align focus improve patient life across globe product remain strongly commit create healthier environment effort positive impact community future generation turn slide recent announcement collaboration corn look across biotech pharma company drug pipeline grow need provide system solution support increasingly sensitive complex molecule come change increase regulatory environment high requirement performance data combination product system level regulatory change drive drug manufacturer look west reduce risk specifically specify system package rather individual component excite corn collaborator expand value proposition lead industry component truly integrate system couple elastomer glass response customer exclusive supply technology agreement corn include significant investment capital manufacture capacity expand corn glass technology combine west industry lead component coat technology corn valor glass velocity vial collaboration enable advance pharmaceutical package solution believe integrate system glass single drug master file next level high value product initial focus address need complete system offer time offer broad range system vial prefilled cartridge enter build positive momentum generate introduce full year financial guidance assume approximately organic sale lead strong sale another strong year gross operate profit margin expansion excess basis point guidance include substantial acceleration effort enter integrate system robust book commit order momentum continue expect capital expansion plan additional capacity stay ahead customer demand expect project complete throughout year ready production turn call review financial result detail want revisit long term financial construct past year long term financial construct annual organic sale growth lead sale annual operate profit margin expansion basis point year past five year annual organic sale annual operate profit margin expansion basis point year five year biologics smallest market unit today biologics largest market unit customer emerge biotech large biopharma come west partner reinforce strong participation rate recently approve molecular entity also look future continue demand growth product launch level integrate system update long term construct annual sale growth continue expect expand operate margin basis point year next year turn provide detail financial performance chief financial officer thank good morning review number detail first look revenue profit continue strong sale growth lead strong revenue performance proprietary market unit take margin growth quarter balance sheet takeaway finally review guidance first financial result summarize slide reconciliation measure describe slide record sale million quarter represent organic sale growth relate revenue estimate approximately million quarter revenue include assessment component associate vaccine treatment diagnosis patient offset lower sale customer affect lower volume pandemic look slide proprietary product sale grow organically quarter high value product make approximately proprietary product sale quarter grow double digit solid momentum across market unit look performance market unit biologics market unit deliver strong double digit growth lead component generic pharma market unit also experience double digit growth lead sale component contract manufacture organic sale decline fourth quarter primarily drive lower sale healthcare relate medical device continue improvement gross profit record million gross profit million last year gross profit margin basis point expansion period last year improvement adjust operate profit million record quarter compare million period last year increase adjust operate profit margin basis point increase period last year finally adjust dilute grow exclude stock base compensation benefit grow approximately review growth driver revenue profit slide show contribution sale growth quarter volume contribute million percentage point growth include approximately million incremental volume drive relate demand sale price increase contribute million percentage point growth look margin performance slide show consolidate gross profit margin proprietary product fourth quarter gross profit margin basis point margin achieve fourth quarter driver continue improvement proprietary product gross profit margin favorable product sell drive growth high value product production efficiency sale price increase partially offset increase overhead inclusive compensation contract manufacture fourth quarter gross profit margin basis point margin achieve fourth quarter decrease margin largely attribute increase material product sell look balance sheet review term generate cash slide list cash flow metric operate cash flow million year increase million compare period last year increase operate cash flow period adversely impact work capital increase increase payment spend million capital expenditure increase majority incremental capex leverage increase high value product manufacture capacity within exist facility expand capacity exist site major facility modification piece equipment keep pace grow demand continue increase capacity site able leverage exist asset base support proprietary product manufacture example site formerly contract manufacture site transform half manufacture capacity support proprietary product elastomer batch line leverage close proximity site jersey shore flex global infrastructure phase capacity expansion position continue growth work capital approximately billion increase million primarily higher account receivable increase sale higher inventory level increase cash position cash balance million million higher balance increase cash primarily strong operate result period offset share repurchase program higher capex turn guidance slide provide high level summary full year sale guidance range billion billion estimate headwind million base current foreign exchange rate expect organic sale growth approximately comprise teen growth proprietary business forecast include teen growth base business teen growth relate revenue contract manufacture forecast single digit negative growth expect contract manufacture return growth expect full year report dilute guidance range also capex guidance million year element want bring attention review guidance estimate headwind impact approximately base current foreign currency exchange rate guidance exclude future benefit stock base compensation summarize takeaway fourth quarter strong line growth proprietary gross profit margin improvement growth operate profit margin growth adjust dilute growth operate cash flow deliver line pillar execute innovate grow like turn call back green chief executive officer thank summarize slide excellent financial performance report today continue reaffirm strategy work strong base business prove market lead approach deliver unique value customer global operation efficiently manufacture deliver product complex environment focus service quality continue accelerate capital spend across operation meet current anticipate future growth realize product critical healthcare across globe dedicate support patient health today future ready take question thank